🇺🇸 PEG-rIL-29 in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 5

Most-reported reactions

1. Anaemia — 1 report (20%)
2. Anxiety — 1 report (20%)
3. Colitis — 1 report (20%)
4. Constipation — 1 report (20%)
5. Small Intestinal Haemorrhage — 1 report (20%)

Source database →

Frequently asked questions

Is PEG-rIL-29 approved in United States?

PEG-rIL-29 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for PEG-rIL-29 in United States?

ZymoGenetics is the originator. The local marketing authorisation holder may differ — check the official source linked above.